Turning Point Therapeutics, Inc.
Macrocycles for use in treating disease
Last updated:
Abstract:
The present disclosure relates to certain chiral diaryl macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat cancer.
Status:
Grant
Type:
Utility
Filling date:
26 Mar 2021
Issue date:
12 Oct 2021